first floor thaives inn house, 3-4 holborn circus, london, EC1N 2HA
Website
-
pharmasynt (u.k.) limitedEstimated Valuation
£13.8k
Pomanda estimates the enterprise value of PHARMASYNT (U.K.) LIMITED at £13.8k based on a Turnover of £53.6k and 0.26x industry multiple (adjusted for size and gross margin).
pharmasynt (u.k.) limitedEstimated Valuation
£23.8k
Pomanda estimates the enterprise value of PHARMASYNT (U.K.) LIMITED at £23.8k based on an EBITDA of £7.4k and a 3.19x industry multiple (adjusted for size and gross margin).
pharmasynt (u.k.) limitedEstimated Valuation
£44.3k
Pomanda estimates the enterprise value of PHARMASYNT (U.K.) LIMITED at £44.3k based on Net Assets of £16.9k and 2.62x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmasynt (u.k.) LimitedOverview
Pharmasynt (u.k.) Limited is a dissolved company that was located in london, EC1N 2HA with a Companies House number of 02598655. It operated in the non-specialised wholesale trade sector, SIC Code 46900. Founded in April 1991, it's largest shareholder was
nishith ranjan datta
with a 50% stake. The last turnover for Pharmasynt (u.k.) Limited was estimated at £53.6k.
Pomanda's financial health check has awarded Pharmasynt (U.K.) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
5 Strong
0 Regular
5 Weak
Size
annual sales of £53.6k, make it smaller than the average company (£12.8m)
£53.6k - Pharmasynt (u.k.) Limited
£12.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 39%, show it is growing at a faster rate (4.3%)
39% - Pharmasynt (u.k.) Limited
4.3% - Industry AVG
Production
with a gross margin of 17.9%, this company has a higher cost of product (27.3%)
17.9% - Pharmasynt (u.k.) Limited
27.3% - Industry AVG
Profitability
an operating margin of 13.3% make it more profitable than the average company (3.8%)
13.3% - Pharmasynt (u.k.) Limited
3.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (43)
2 - Pharmasynt (u.k.) Limited
43 - Industry AVG
Pay Structure
on an average salary of £3k, the company has a lower pay structure (£36.9k)
£3k - Pharmasynt (u.k.) Limited
£36.9k - Industry AVG
Efficiency
resulting in sales per employee of £26.8k, this is less efficient (£309.3k)
£26.8k - Pharmasynt (u.k.) Limited
£309.3k - Industry AVG
Debtor Days
it gets paid by customers after 176 days, this is later than average (56 days)
176 days - Pharmasynt (u.k.) Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (38 days)
44 days - Pharmasynt (u.k.) Limited
38 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmasynt (u.k.) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmasynt (u.k.) Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34.5%, this is a lower level of debt than the average (54.5%)
34.5% - Pharmasynt (u.k.) Limited
54.5% - Industry AVG
PHARMASYNT (U.K.) LIMITED financials
EXPORT
Pharmasynt (U.K.) Limited's latest turnover from April 2019 is £53.6 thousand and the company has net assets of £16.9 thousand. According to their latest financial statements, Pharmasynt (U.K.) Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Apr 2019
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
53,554
61,458
20,044
51,504
32,121
16,545
65,651
16,695
33,586
31,702
Other Income Or Grants
Cost Of Sales
43,950
50,109
16,230
30,146
18,961
9,958
38,372
10,108
20,294
19,115
Gross Profit
9,604
11,349
3,814
21,358
13,160
6,587
27,279
6,587
13,292
12,587
Admin Expenses
2,472
-751
4,997
12,269
10,612
8,046
12,601
6,734
14,994
7,440
Operating Profit
7,132
12,100
-1,183
9,089
2,548
-1,459
14,678
-147
-1,702
5,147
Interest Payable
Interest Receivable
21
20
17
19
26
22
21
Pre-Tax Profit
7,165
12,092
-1,419
9,110
2,568
-1,442
14,697
-121
-1,680
5,168
Tax
-1,388
-2,291
281
-1,830
-471
267
-3,000
306
-1,124
Profit After Tax
5,777
9,801
-1,138
7,280
2,097
-1,175
11,697
-121
-1,374
4,044
Dividends Paid
Retained Profit
5,777
9,801
-1,138
7,280
2,097
-1,175
11,697
-121
-1,374
4,044
Employee Costs
6,000
4,500
4,500
4,500
33,630
33,597
33,178
32,935
32,233
Number Of Employees
2
2
1
1
1
1
1
1
1
EBITDA*
7,446
12,205
-1,183
9,089
2,548
-1,459
14,678
-147
-1,702
5,147
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2019
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
314
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
314
Stock & work in progress
Trade Debtors
25,834
57,151
31,321
Group Debtors
Misc Debtors
219
9
645
59
Cash
36,035
23,569
17,066
30,645
29,133
40,334
42,716
misc current assets
total current assets
25,834
57,151
31,321
36,035
23,569
17,285
30,654
29,133
40,979
42,775
total assets
25,834
57,465
31,321
36,035
23,569
17,285
30,654
29,133
40,979
42,775
Bank overdraft
Bank loan
Trade Creditors
5,310
22,098
5,815
9,229
19,462
23,100
22,841
Group/Directors Accounts
7,555
3,685
78
43
2,986
933
853
other short term finances
hp & lease commitments
other current liabilities
3,996
2,680
2,100
5,100
2,100
2,340
3,101
total current liabilities
5,310
22,098
5,815
11,551
6,365
2,178
14,372
24,548
26,373
26,795
loans
hp & lease commitments
Accruals and Deferred Income
3,600
2,220
2,160
other liabilities
provisions
total long term liabilities
3,600
2,220
2,160
total liabilities
8,910
24,318
7,975
11,551
6,365
2,178
14,372
24,548
26,373
26,795
net assets
16,924
33,147
23,346
24,484
17,204
15,107
16,282
4,585
14,606
15,980
total shareholders funds
16,924
33,147
23,346
24,484
17,204
15,107
16,282
4,585
14,606
15,980
Apr 2019
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
7,132
12,100
-1,183
9,089
2,548
-1,459
14,678
-147
-1,702
5,147
Depreciation
314
105
Amortisation
Tax
-1,388
-2,291
281
-1,830
-471
267
-3,000
306
-1,124
Stock
Debtors
25,834
25,830
31,321
-219
210
9
-645
586
59
Creditors
5,310
16,283
5,815
-9,229
-10,233
-3,638
259
22,841
Accruals and Deferred Income
3,600
60
-1,836
1,316
580
-3,000
3,000
-240
-761
3,101
Deferred Taxes & Provisions
Cash flow from operations
-10,866
427
-28,244
8,575
2,876
-13,631
4,436
-3,380
-2,484
29,906
Investing Activities
capital expenditure
-314
-419
Change in Investments
cash flow from investments
-314
-419
Financing Activities
Bank loans
Group/Directors Accounts
-7,555
3,870
3,607
35
-2,943
2,053
80
853
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
11,147
-9,900
11,936
interest
21
20
17
19
26
22
21
cash flow from financing
11,147
-7,555
3,891
3,627
52
-2,924
-7,821
102
12,810
cash and cash equivalents
cash
-36,035
12,466
6,503
-13,579
1,512
-11,201
-2,382
42,716
overdraft
change in cash
-36,035
12,466
6,503
-13,579
1,512
-11,201
-2,382
42,716
pharmasynt (u.k.) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharmasynt (u.k.) limited. Get real-time insights into pharmasynt (u.k.) limited's credit score, group structure and payment trends.
Perform a competitor analysis for pharmasynt (u.k.) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other undefined companies, companies in EC1N area or any other competitors across 12 key performance metrics.
pharmasynt (u.k.) limited Ownership
PHARMASYNT (U.K.) LIMITED group structure
Pharmasynt (U.K.) Limited has no subsidiary companies.
Ultimate parent company
PHARMASYNT (U.K.) LIMITED
02598655
PHARMASYNT (U.K.) LIMITED Shareholders
The largest shareholders in Pharmasynt (U.K.) Limited include Nishith Ranjan Datta and Heather Margaret Datta.
nishith ranjan datta
50%
heather margaret datta
50%
pharmasynt (u.k.) limited directors
Pharmasynt (U.K.) Limited currently has 1 director, Nishith Datta serving since Apr 1992.
first floor thaives inn house, 3-4 holborn circus, london, EC1N 2HA
Bank
BARCLAYS BANK PLC
Legal Advisor
-
pharmasynt (u.k.) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to pharmasynt (u.k.) limited. Currently there are 1 open charges and 0 have been satisfied in the past.
pharmasynt (u.k.) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMASYNT (U.K.) LIMITED. This can take several minutes, an email will notify you when this has completed.
pharmasynt (u.k.) limitedCompanies House Filings - See Documents
